Literature DB >> 9357395

Vasodilation in black Americans: attenuated nitric oxide-mediated responses.

C M Stein1, C C Lang, R Nelson, M Brown, A J Wood.   

Abstract

BACKGROUND: Attenuated vasodilation in response to the intra-arterial administration of the beta-adrenergic agonist isoproterenol (INN, isoprenaline), an endothelium-independent vasodilator, has previously been observed in normotensive black Americans. To determine whether this reflected a more generalized attenuation of responses to vasodilators, we compared forearm blood flow responses to the endothelium-dependent vasodilator methacholine and the endothelium-independent vasodilator sodium nitroprusside in young normotensive black men and white men.
METHODS: Forearm blood flow responses to the intra-arterial administration of isoproterenol (10 to 400 ng/min), methacholine (0.25 to 8 micrograms/min), and sodium nitroprusside (0.25 to 8 micrograms/min) were measured with use of venous occlusion plethysmography in 11 normotensive black men (mean +/- SE age, 30.5 +/- 2.2 years) and nine normotensive white men (mean age, 28.0 +/- 3.2 years).
RESULTS: Baseline characteristics, including baseline forearm blood flow, were similar in the black and the white subjects. Vasodilation in response to isoproterenol, sodium nitroprusside, and methacholine was significantly attenuated in black subjects, resulting respectively in a 3.7-fold, 3.6-fold, and 5.0-fold increase in forearm blood flow in black subjects and a 7.5-fold, 5.2-fold, and 6.9-fold increase in forearm blood flow in white subjects (ANOVA; isoproterenol, p < 0.0001; sodium nitroprusside, p < 0.0001; methacholine, p = 0.01).
CONCLUSIONS: Our finding of attenuated nitric oxide-mediated vasodilation in response to methacholine and sodium nitroprusside in healthy black American men suggests that attenuated vasodilation in black subjects is a relatively generalized phenomenon, resulting in attenuated responses to multiple vasodilators that act through different receptor- and nonreceptor-mediated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357395     DOI: 10.1016/S0009-9236(97)90122-3

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  43 in total

1.  Alternative splicing for the alpha1 subunit of soluble guanylate cyclase.

Authors:  D Ritter; J F Taylor; J W Hoffmann; L Carnaghi; S J Giddings; H Zakeri; P Y Kwok
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.

Authors:  Ewa D Marczak; Jacqui Marzec; Darryl C Zeldin; Steven R Kleeberger; Nancy J Brown; Mias Pretorius; Craig R Lee
Journal:  Pharmacogenet Genomics       Date:  2012-08       Impact factor: 2.089

Review 3.  Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Pro position.

Authors:  Jay N Cohn
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

Review 4.  Heart failure in African Americans: unique etiology and pharmacologic treatment responses.

Authors:  Clyde W Yancy
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

5.  Abnormal endothelial function in young African-American females: discordance with blood flow.

Authors:  T L Bransford; J A St Vrain; M Webb
Journal:  J Natl Med Assoc       Date:  2001-04       Impact factor: 1.798

6.  Endogenous nitric oxide formation correlates negatively with circulating matrix metalloproteinase (MMP)-2 and MMP-9 levels in black subjects.

Authors:  Ingrid F Metzger; Valéria C Sandrim; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

7.  Elderly blacks have a blunted sympathetic neural responsiveness but greater pressor response to orthostasis than elderly whites.

Authors:  Yoshiyuki Okada; M Melyn Galbreath; Sara S Jarvis; Tiffany B Bivens; Wanpen Vongpatanasin; Benjamin D Levine; Qi Fu
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

Review 8.  Beta blocker therapy in African American patients with heart failure.

Authors:  Sidney Goldstein
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

Review 9.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

10.  The effect of salt on renal damage in eNOS-deficient mice.

Authors:  Geraldine Daumerie; Lakeesha Bridges; Sadiqa Yancey; Wendell Davis; Paul Huang; Joseph Loscalzo; Mildred A Pointer
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.